OpenEvidence’s Meteoric Rise Is Huge For Doctors
Forbes Healthcare
JULY 28, 2025
In its most recent funding round, it raised a $210 million Series B from prominent investors such as Google Ventures and Kleiner Perkins, bringing the company’s valuation to nearly $3.5 This also means that there is less time for professional development and continuing education.
Let's personalize your content